Journal
PHARMACOGENETICS
Volume 14, Issue 12, Pages 805-811Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00008571-200412000-00003
Keywords
5-HT2B receptor (HTR2B); association study; double-mutant; genome scan; neuropsychiatric genetics; reward; single nucleotide polymorphism (SNP)
Ask authors/readers for more resources
Objective and methods 5-Hydroxytryptamine (serotonin) receptor 2B (HTR2B) is involved in brain development. Although expressed in the human brain, HTR2B has not been investigated much for its role in higher brain functions. Here we describe a genome-scan with 391 simple sequence repeat markers in 300 Caucasians, identifying HTR2B gene as a candidate for drug abuse vulnerability. Results From DNA re-sequencing of 110 subjects, we discovered three novel single nucleotide polymorphisms (SNPs), two of which confer a double-mutant of the receptor protein in a drug-abusing population. Arg6, a conserved basic residue, and the conserved acidic Glu42 are mutated simultaneously into Gly, termed R6G/E42G. Furthermore, this double-mutant tends to associate with drug abuse (P = 0.08 by chi(2) test). The third SNP that is a synonymous mutation in the codon of Gln11 showed significant association with drug abuse (P = 0.0335 by Fisher's exact test). Conclusion Our data are the first suggesting that HTR2B contributes to brain architecture and pathways that are involved in illegal drug reward. (C) 2004 Lippincott Williams Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available